Deaths related to pulmonary embolism and cardiovascular events before and during the 2020 COVID-19 pandemic: An epidemiological analysis of data from an Italian high-risk area
- PMID: 35219931
- PMCID: PMC8858636
- DOI: 10.1016/j.thromres.2022.02.008
Deaths related to pulmonary embolism and cardiovascular events before and during the 2020 COVID-19 pandemic: An epidemiological analysis of data from an Italian high-risk area
Abstract
Background: Pulmonary embolism is a known complication of coronavirus disease 2019 (COVID-19). Epidemiological population data focusing on pulmonary embolism-related mortality is limited.
Methods: Veneto is a region in Northern Italy counting 4,879,133 inhabitants in 2020. All ICD-10 codes from death certificates (1st January 2018 to 31st December 2020) were examined. Comparisons were made between 2020 (COVID-19 outbreak) and the average of the two-year period 2018-2019. All-cause, COVID-19-related and the following cardiovascular deaths have been studied: pulmonary embolism, hypertensive disease, ischemic heart disease, atrial fibrillation/flutter, and cerebrovascular diseases.
Results: In 2020, a total of 56,412 deaths were recorded, corresponding to a 16% (n = 7806) increase compared to the period 2018-2019. The relative percentage increase during the so-called first and second waves was 19% and 44%, respectively. Of 7806 excess deaths, COVID-19 codes were reported in 90% of death certificates. The percentage increase in pulmonary embolism-related deaths was 27% (95%CI 19-35%), 1018 deaths during the year 2020, compared to 804 mean annual deaths in the period 2018-2019. This was more evident among men, who experience an absolute increase of 147 deaths (+45%), than in women (+67 deaths; +14%). The increase was primarily driven by deaths recorded during the second wave (+91% in October-December). An excess of deaths, particularly among men and during the second wave, was also observed for other cardiovascular diseases, notably hypertensive disease, atrial fibrillation, cerebrovascular disease, and ischemic heart disease.
Conclusions: We observed a considerable increase of all-cause mortality during the year 2020. This was mainly driven by COVID-19 and its complications. The relative increase in the number of pulmonary embolism-related deaths was more prominent during the second wave, suggesting a possible underdiagnosis during the first wave.
Copyright © 2022 The Authors. Published by Elsevier Ltd.. All rights reserved.
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures
Similar articles
-
Mortality Related to Chronic Obstructive Pulmonary Disease during the COVID-19 Pandemic: An Analysis of Multiple Causes of Death through Different Epidemic Waves in Veneto, Italy.Int J Environ Res Public Health. 2022 Oct 7;19(19):12844. doi: 10.3390/ijerph191912844. Int J Environ Res Public Health. 2022. PMID: 36232144 Free PMC article.
-
Excess Mortality in Italy During the COVID-19 Pandemic: Assessing the Differences Between the First and the Second Wave, Year 2020.Front Public Health. 2021 Jul 16;9:669209. doi: 10.3389/fpubh.2021.669209. eCollection 2021. Front Public Health. 2021. PMID: 34336767 Free PMC article.
-
The spread in time and space of COVID-19 pandemic waves: the Italian experience from mortality data analyses.Front Public Health. 2024 Feb 28;12:1324033. doi: 10.3389/fpubh.2024.1324033. eCollection 2024. Front Public Health. 2024. PMID: 38481837 Free PMC article.
-
Prevalence of cardiovascular diseases in COVID-19 related mortality in the United States.Prog Cardiovasc Dis. 2022 Sep-Oct;74:122-126. doi: 10.1016/j.pcad.2022.09.002. Epub 2022 Oct 21. Prog Cardiovasc Dis. 2022. PMID: 36279944 Free PMC article. Review.
-
Secondary Cerebrovascular Prevention in Light of the COVID-19 Pandemic.Curr Treat Options Neurol. 2020;22(9):28. doi: 10.1007/s11940-020-00634-4. Epub 2020 Aug 5. Curr Treat Options Neurol. 2020. PMID: 32834715 Free PMC article. Review.
Cited by
-
Diabetes as a cause of death across different COVID-19 epidemic waves.Diabetes Res Clin Pract. 2022 Aug;190:109984. doi: 10.1016/j.diabres.2022.109984. Epub 2022 Jul 6. Diabetes Res Clin Pract. 2022. PMID: 35803315 Free PMC article.
-
COVID-19 infection and its impact on case fatality in patients with pulmonary embolism.Eur Respir J. 2023 Jan 27;61(1):2200619. doi: 10.1183/13993003.00619-2022. Print 2023 Jan. Eur Respir J. 2023. PMID: 35981745 Free PMC article.
-
Urokinase-type plasminogen activator and plasminogen activator inhibitor-1 complex as a serum biomarker for COVID-19.Front Immunol. 2024 Jan 11;14:1299792. doi: 10.3389/fimmu.2023.1299792. eCollection 2023. Front Immunol. 2024. PMID: 38313435 Free PMC article.
-
Mortality Related to Chronic Obstructive Pulmonary Disease during the COVID-19 Pandemic: An Analysis of Multiple Causes of Death through Different Epidemic Waves in Veneto, Italy.Int J Environ Res Public Health. 2022 Oct 7;19(19):12844. doi: 10.3390/ijerph191912844. Int J Environ Res Public Health. 2022. PMID: 36232144 Free PMC article.
-
Pulmonary Embolism in Women: A Systematic Review of the Current Literature.J Cardiovasc Dev Dis. 2022 Jul 25;9(8):234. doi: 10.3390/jcdd9080234. J Cardiovasc Dev Dis. 2022. PMID: 35893223 Free PMC article. Review.
References
-
- Solomon M.D., McNulty E.J., Rana J.S., Leong T.K., Lee C., Sung S.H., et al. The COVID-19 pandemic and the incidence of acute myocardial infarction. N. Engl. J. Med. 2020;383(7):691–693. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical